Xeris Biopharma Holdings, Inc. (XERS)
7.61
+0.09
(+1.20%)
USD |
NASDAQ |
Jan 20, 16:00
7.69
+0.08
(+1.05%)
After-Hours: 20:00
Xeris Biopharma Holdings EPS Diluted (Quarterly): 0.0035 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Corcept Therapeutics, Inc. | 0.1621 |
| Plus Therapeutics, Inc. | -0.0412 |
| Assertio Holdings, Inc. | 1.612 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 0.621M |
| Revenue (Quarterly) | 74.38M |
| Total Expenses (Quarterly) | 73.76M |
| Enterprise Value | 1.429B |
| Gross Profit Margin (Quarterly) | 81.57% |
| Profit Margin (Quarterly) | 0.83% |
| Earnings Yield | -1.36% |
| Operating Earnings Yield | 0.81% |
| Normalized Earnings Yield | -1.359 |